These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33526838)

  • 1. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection.
    Zhang J; Chen C; Li A; Jing W; Sun P; Huang X; Liu Y; Zhang S; Du W; Zhang R; Liu Y; Gong A; Wu J; Jiang X
    Nat Nanotechnol; 2021 May; 16(5):538-548. PubMed ID: 33526838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse.
    Zhang Y; Xi K; Fu Z; Zhang Y; Cheng B; Feng F; Dong Y; Fang Z; Zhang Y; Shen J; Wang M; Han X; Geng H; Sun L; Li X; Chen C; Jiang X; Ni S
    Nat Commun; 2024 May; 15(1):4241. PubMed ID: 38762500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy.
    Chen C; Jing W; Chen Y; Wang G; Abdalla M; Gao L; Han M; Shi C; Li A; Sun P; Jiang X; Yang Z; Zhang S; Zhang J; Tang C; Liu Y; Zhang R; Xu F; Dong B; Li X; Liu M; Qiang B; Sun Y; Wei X; Li J; Hu Q; Jiang X
    Sci Transl Med; 2022 Aug; 14(656):eabn1128. PubMed ID: 35921473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
    Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
    Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
    Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations.
    Sun S; Shi D; Liu J; Lu J; Dou P; Zhou Z; Chen Y
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36912553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracavitary Spraying of Nanoregulator-Encased Hydrogel Modulates Cholesterol Metabolism of Glioma-Supportive Macrophage for Postoperative Glioblastoma Immunotherapy.
    Dong Y; Zhang J; Wang Y; Zhang Y; Rappaport D; Yang Z; Han M; Liu Y; Fu Z; Zhao X; Tang C; Shi C; Zhang D; Li D; Ni S; Li A; Cui J; Li T; Sun P; Benny O; Zhang C; Zhao K; Chen C; Jiang X
    Adv Mater; 2024 Mar; 36(13):e2311109. PubMed ID: 38127403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and structure-property relationships of an injectable thiol-Michael addition hydrogel toward compatibility with glioblastoma therapy.
    Khan ZM; Wilts E; Vlaisavljevich E; Long TE; Verbridge SS
    Acta Biomater; 2022 May; 144():266-278. PubMed ID: 35296443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma.
    Wang X; Ye L; He W; Teng C; Sun S; Lu H; Li S; Lv L; Cao X; Yin H; Lv W; Xin H
    J Control Release; 2022 May; 345():786-797. PubMed ID: 35367277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
    Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
    Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
    Desland FA; Hormigo A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
    Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF
    Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice.
    Bianco J; Bastiancich C; Joudiou N; Gallez B; des Rieux A; Danhier F
    J Neurosci Methods; 2017 Jun; 284():96-102. PubMed ID: 28472680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.
    Maggio D; Ho WS; Breese R; Walbridge S; Wang H; Cui J; Heiss JD; Gilbert MR; Kovach JS; Lu RO; Zhuang Z
    J Neurooncol; 2020 Jun; 148(2):231-244. PubMed ID: 32342332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy.
    Muenchmeier N; Boecker S; Bankel L; Hinz L; Rieth N; Lapa C; Mendler AN; Noessner E; Mocikat R; Nelson PJ
    PLoS One; 2013; 8(8):e72749. PubMed ID: 24023642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy.
    Moore KM; Murthy AB; Graham-Gurysh EG; Hingtgen SD; Bachelder EM; Ainslie KM
    ACS Biomater Sci Eng; 2020 Jul; 6(7):3762-3777. PubMed ID: 33463324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
    Jiang Y; Han QJ; Zhang J
    World J Gastroenterol; 2019 Jul; 25(25):3151-3167. PubMed ID: 31333308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.